Table 2.
Symptoms and domains covered by questionnaires to assess asthma control.
| ACT | ACQ | APGAR | C-ACT | NAEPP | RCP3Q | VAS | |
|---|---|---|---|---|---|---|---|
| Daytime symptoms | x | x | x | x | x | NA | |
| Limitations on activities | x | x | x | x | x | x | NA |
| Lung function | x | NA | |||||
| Shortness of breath/chest tightness | x | x | x | NA | |||
| Nocturnal symptoms | x | x | x | x | x | x | NA |
| Patient’s perception of control | x | NA | |||||
| Overall symptoms | x | NA | |||||
| Wheezing | x | x | NA | ||||
| Coughing | x | x | NA | ||||
| Triggers | x | NA | |||||
| (Rescue) β-agonist use | x | x | x | x | NA | ||
| Effectiveness of reliever medication | x | NA | |||||
| Exacerbationsa | x | NA |
ACT Asthma Control Test, ACQ Asthma Control Questionnaire, APGAR Activities Persistent triGGers Asthma medications Response to therapy, C-ACT Childhood Asthma Control Test, NAEPP National Asthma Education and Prevention Program, RCP3Q Royal College of Physicians’ ‘three questions’, VAS Visual Analog Scale
aRequiring oral systemic corticosteroids.